Therapeutic applications of opioid antagonists

Chimica Oggi

Volumn 24, Issue 3, 2006, Pages 54-57

  Cunningham, Christopher W ^a   Coop, Andrew ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33746282245     PISSN: 0392839X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (66)

1. J. Hughes et al., Nature, 258, pp. 577-680 (1975)
2. W.R. Martin et al., J Pharmacol Exp Ther., 197, pp. 517-532 (1976)
3. P.E. Gilbert, W.R. Martin, J Pharmacol Exp Ther., 198, pp. 495-499 (1976)
4. M.H. Ossipov et al., J Neurobiol., 61, 126-48 (2004)
5. A. DeLuca, I.M. Coupar, Pharmacol Ther, 69, pp. 103-15 (1996)
6. J.B. Wang et al., FEBS Lett, 338, pp. 217-22 (1994)
7. E. Mansson et al., Biochem Biophys Res Commun., 202, pp. 1431-1437 (1994)
8. B.L. Kieffer et al., Proc Natl Acad Sci USA, 89, pp. 12048-12052 (1992)
9. C.J. Evans et al., Science, 258, pp. 1952-1955 (1992)
10. G.W. Pasternak, Neuropharmacology, 47, pp. 312-323 (2004)
11. S. Mercandante, Cancer, 86, pp. 1856-1866 (1999)
12. L. Lasagna, H.K. Beecher, J Pharmacol Exp Ther., 112, pp. 356-363 (1954)
13. J.D. Leander, Eur J Pharmacol, 86, pp. 467-470 (1983)
14. D.M. Zimmerman, J.D. Leander, J Med Chem., 33, pp. 895-902 (1990)
15. F.M. Leslie, Pharm Rev, 39, p. 197 (1987)
16. C.P. France, J.H. Woods, J Pharmacol Exp Ther., 254, pp. 626-632 (1990)
17. H. Schmidhammer et al., J Med Chem., 32, pp. 418-421 (1989)
18. A. Marki et al., Eur J Pharmacol., 383, pp. 209-214 (1999)
19. P.S. Portoghese et al., Eur J Pharmacol., 146, pp. 185-186 (1988)
20. M. D. Metcalf, A. Coop, AAPSJ, 7, E704-22 (2005)
21. R. Cotton et al., Eur J Pharmacol., 97, pp. 331-332 (1984)
22. L.J. Pelton et al., J Med Chem., 29, pp. 2370-2375 (1986)
23. R. Schwyzer, Ann NY Acad Sci, 297, pp. 3-26 (1977)
24. M.A. Bennett et al., J Med Chem., 45, pp. 5617-5619 (2002)
25. C.T. Dooley et al., Proc Natl Acad Sci USA, 90, pp. 10811-10815 (1993)
26. M.J. Kreek, F.J. Vocci, J Subst Abuse Treat, 23, pp. 93-105 (2002)
27. R.S. Schottenfeld et al., Biol Psychiatry, 47, p. 1072 (2000)
28. S.L. Walsh et al., Clin Pharmacol Ther., 55, pp. 569-580 (1994)
29. F. Vocci, W. Ling, Pharmacol Ther, 108, pp. 94-108 (2005)
30. L.L. Weinhold et al., Drug Alcohol Depend, 30, pp. 263-274 (1992)
31. K.A. Handal et al., Ann Emerg Med., 12, pp. 438-445 (1983)
32. J.W. Cornish et al., J Subst Abuse Treat, 14, pp. 529-534 (1997)
33. J. Ward et al., Lancet, 353, pp. 221-226 (1999)
34. S.C. Prinster et al., Pharmacol Rev, 57, pp. 289-298 (2005)
35. E.E. Abdelhamid et al., J Pharmacol Exp Ther., 258, pp. 299-303 (1991)
36. I. Gomes et al., J Neurosci., 20, RC110 (2004)
37. M.E. Fundytus et al., Eur J Pharmacol., 286, pp. 105-108 (1995)
38. S. Ananthan et al., J Med Chem., 42, pp. 3527-3538 (1999)
39. P.W. Schiller et al., J Med Chem., 42, pp. 3520-3526 (1999)
40. B.L. Kieffer, Trends Pharmacol Sci., 20, pp. 19-26 (1999)
41. C.S. Yuan, J Support Oncol., 2, pp. 111-117 (2004)
42. J.F. Foss, Am J Surg, 182, 19S-26S (2001)
43. A.N. Kotake et al., Xenobiotica, 19, pp. 1247-1254 (1989)
44. B.C. Wolff et al., Surg., 240, pp. 728-735 (2004)
45. D.M. Zimmerman et al., J Med Chem., 37, pp. 2262-2265 (1994)
46. W.K. Schmidt, Am J Surg., 182, 27S-38S (2001)
47. A. Herz, Psychopharmacology (Berl), 129, pp. 99-111 (1997)
48. H.L. Altshuler et al., life Sci., 26, pp. 679-688 (1980)
49. B.J. Mason et al., Alcohol Clin Exp Res., 18, pp. 1162-1167 (1994)
50. D.S. Wang et al., J Emerg Med., 16, pp. 471-475 (1998)
51. J.C. Froehlich et al., Pharmacol Biochem Behav., 35, pp. 385-390 (1990)
52. P. Hyytiå, Pharmacol Biochem Behav., 45, pp. 697-701 (1993)
53. R. Spanagel, W. Zieglgansberger, Trends Pharmacol Sci., 18, pp. 54-59 (1997)
54. J.M. Mitchell et al., Psychopharmacology (Berl), 182, pp. 384-392 (2005)
55. K.A. Trujillo et al., Brain Res, 518, pp. 244-256 (1990)
56. R.L. Cole et al., Neuron, 14, pp. 813-823 (1995)
57. S.D. Mague et al., J Pharmacol Exp Ther., 305, pp. 323-330 (2003)
58. F.H. Gawin, H.D. Kleber, Arch Gen Psychiatry, 43, pp. 107-113 (1986)
59. F.I. Carroll et al., Eur J Pharmacol., 524, pp. 89-94 (2005)
60. P.M. Beardsley et al., Psychopharmacology (Berl), 183, pp. 118-126 (2005)
61. L. McCarthy et al., Drug Alcohol Depend, 62, pp. 111-123 (2001)
62. J.N. Mehrishi, I.H. Mills, Clin Immunol Immunopathol, 27, pp. 240-249 (1983)
63. I. Szabo et al., J Pharmacol Exp Ther., 267, pp. 703-706 (1993)
64. M. Rojavin et al., Life Sci., 53, pp. 997-1006 (1993)
65. K. Arakawa et al., Transplant Proc., 25, pp. 738-740 (1993)
66. C. Gavériaux-Ruff et al., J Pharmacol Exp Ther., 298, pp. 1193-1198 (2001)